ResearcherPathologisches InstitutActive in the last 2 years
Sai Agash Surendran
Matched on OpenAlex author ID A5025172764. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 2 papers · 2026: 1 paper
Papers 5
- Circulating free bacterial DNA as a novel biomarker for monitoring therapy response in patients with advanced pancreatic cancer. Co-author DOI 10.1016/j.ejca.2026.117040↗
- Intratumoral bacterial abundance confers poor response to adjuvant gemcitabine in resected pancreatic cancer patients which is mitigated by postoperative antib… First author DOI 10.1038/s41416-025-03078-2↗
- The Prognostic, Predictive and Clinicopathological Implications of KRT81/HNF1A- and GATA6-Based Transcriptional Subtyping in Pancreatic Cancer. First author DOI 10.3390/biom15030426↗
- TPX2 expression as a negative predictor of gemcitabine efficacy in pancreatic cancer. First author DOI 10.1038/s41416-023-02295-x↗
- Bacterial Lipopolysaccharide as a Negative Predictor of Adjuvant Gemcitabine Efficacy in Pancreatic Cancer. Co-author DOI 10.1093/jncics/pkac039↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Michael Guenther · 5 shared papers, 2022–2026 · strength 1.18
- Paper Intratumoral bacterial abundance confers poor response to adjuvant gemcitabine in resected pancreatic cancer patients w… DOI 10.1038/s41416-025-03078-2↗
- Paper Circulating free bacterial DNA as a novel biomarker for monitoring therapy response in patients with advanced pancreati… DOI 10.1016/j.ejca.2026.117040↗
- Paper The Prognostic, Predictive and Clinicopathological Implications of KRT81/HNF1A- and GATA6-Based Transcriptional Subtypi… DOI 10.3390/biom15030426↗
- Steffen Ormanns · 5 shared papers, 2022–2026 · strength 1.18
- Paper Intratumoral bacterial abundance confers poor response to adjuvant gemcitabine in resected pancreatic cancer patients w… DOI 10.1038/s41416-025-03078-2↗
- Paper Circulating free bacterial DNA as a novel biomarker for monitoring therapy response in patients with advanced pancreati… DOI 10.1016/j.ejca.2026.117040↗
- Paper The Prognostic, Predictive and Clinicopathological Implications of KRT81/HNF1A- and GATA6-Based Transcriptional Subtypi… DOI 10.3390/biom15030426↗
- Volker Heinemann · 4 shared papers, 2022–2026 · strength 0.88
- Paper Circulating free bacterial DNA as a novel biomarker for monitoring therapy response in patients with advanced pancreati… DOI 10.1016/j.ejca.2026.117040↗
- Paper The Prognostic, Predictive and Clinicopathological Implications of KRT81/HNF1A- and GATA6-Based Transcriptional Subtypi… DOI 10.3390/biom15030426↗
- Paper TPX2 expression as a negative predictor of gemcitabine efficacy in pancreatic cancer. DOI 10.1038/s41416-023-02295-x↗
- Stefan Hubert Boeck · 4 shared papers, 2022–2026 · strength 0.88
- Paper Circulating free bacterial DNA as a novel biomarker for monitoring therapy response in patients with advanced pancreati… DOI 10.1016/j.ejca.2026.117040↗
- Paper The Prognostic, Predictive and Clinicopathological Implications of KRT81/HNF1A- and GATA6-Based Transcriptional Subtypi… DOI 10.3390/biom15030426↗
- Paper TPX2 expression as a negative predictor of gemcitabine efficacy in pancreatic cancer. DOI 10.1038/s41416-023-02295-x↗
- Michael Haas · 2 shared papers, 2023–2025 · strength 0.44
- Jens Werner · 2 shared papers, 2022–2023 · strength 0.33
- Brigitte Kimmel · 1 shared paper, 2026 · strength 0.29
- Danmei Zhang · 1 shared paper, 2026 · strength 0.29
- Volker Kunzmann · 1 shared paper, 2026 · strength 0.29
- Julia V. Mayerle · 1 shared paper, 2022 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.